section name header

Pronunciation

sye-ME-ti-deen audio

Classifications

Therapeutic Classification: antiulcer agents

Pharmacologic Classification: histamine h2 antagonists

Indications

REMS

Unlabeled Use:

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Well absorbed following oral administration.

Distribution: Enters breast milk and cerebrospinal fluid.

Metabolism/Excretion: 30% metabolized by the liver; remainder is eliminated unchanged by the kidneys.

Half-life: 2 hr.

Time/Action Profile

ROUTEONSETPEAKDURATION
PO30 min45–90 min4–5 hr

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: ARRHYTHMIAS.

Endo: gynecomastia.

GI: constipation, diarrhea, hepatitis, nausea.

GU: ↓ sperm count, erectile dysfunction.

Hemat: anemia, AGRANULOCYTOSIS, APLASTIC ANEMIA, neutropenia, thrombocytopenia.

Neuro: confusion, dizziness, drowsiness, hallucinations, headache.

Misc: hypersensitivity reactions.

Interactions

Drug-Drug:

Drug-Natural Products:

Route/Dosage

see Calculator

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Tagamet

Code

NDC Code*